24 Sep 2021 11:10
AIM WINNERS & LOSERS: In The Style shares shredded by profit warning
AIM WINNERS & LOSERS: In The Style shares shredded by profit warning
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Imperial Innovations Group Share News (IVO)
IVO Share
Price
IVO Share
News
IVO Share
Chat
IVO Share
Trades
IVO
Live RNS
IVO Share
Charts
IVO Broker
Ratings
IVO Directors
Deals
IVO Financial
Diary
IVO
Fundamentals
IVO Short
Positions
IVO
Media
Imperial Innovations Group Information
- There is currently no data for IVO
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Imperial Innovations portfolio value rises as companies near IPO
Wed, 16th Oct 2013 11:25
Imperial Innovations accompanied news of a full year rise in its portfolio value with the announcement of a Nasdaq flotation for portfolio company Oxford Immunotec.The university spin-out group said had "a number" of companies in its portfolio also ready for initial public offering (IPO) or trade sale, as the portfolio had increased in value by 21% to £188.2m by the July 31st year-end.Although profits had slipped from £5.1m to £3.8m, net assets crept up from £228.2m to £230.5m with £22.2m invested across 28 portfolio companies. Allergy specialist Circassia, 18% owned by II, posted the largest gain in fair value of £8.5m after highly encouraging clinical trials.Oxford Immunotec, a medical diagnostics company founded with the help of current 8% shareholder II in 2002, plans to raise $86m in its US IPO.The group had available cash of £80m at the year-end, including an undrawn £30m loan from the European Investment Bank.Shares in Imperial Innovations were down 1.4% to 350p at 12:00 on Wednesday.OH
More News
5 Jan 2017 16:45
Imperial Innovations completes quick-change to Touchstone
(ShareCast News) - Imperial Innovations Group announced on Thursday that, further to the shareholder approval received at its AGM on 21 November 2016, the change of the company's name to Touchstone Innovations took effect on 4 January. The AIM-traded firm added that, with effect from 0800 GMT on Thu
Read more28 Oct 2016 14:18
Imperial Innovations to change name to 'Touchstone'
(ShareCast News) - Imperial Innovations Group announced on Friday that at its annual general meeting on 21 November, it will be seeking shareholder approval to change the name of the company to Touchstone Innovations. The AIM-traded group was originally formed as the technology transfer office for I
Read more24 Oct 2016 15:04
Imperial Innovations celebrates investment momentum
(ShareCast News) - Imperial Innovations Group noted on Monday that its portfolio company, Veryan Medical, has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D Self-Expanding Stent System. The AIM-traded firm said the MIMICS-2 study is a prospective, multicentre, interventiona
Read more13 Oct 2016 08:36
Imperial Innovations' increases investments as pre-tax loss widens
(ShareCast News) - Imperial Innovations' annual pre-tax loss widened while the technology commercialisation and investment company increased investments across its business with universities and a joint venture. For the year ended 31 July, the pre-tax loss widened to £63.1m from £15.1m, last year, w
Read more6 Oct 2016 15:15
6 Oct 2016 15:15
Imperial Innovations shares up on portfolio company progress
(ShareCast News) - Imperial Innovations Group updated the market on Thursday, noting that its portfolio company TopiVert Pharma has announced that the first patients have been dosed in its Phase IIa proof-of-concept study to evaluate the safety, tolerability and efficacy of a rectal formulation of T
Read more3 Oct 2016 15:20
Imperial Innovations sells Permasense portfolio business
(ShareCast News) - AIM-listed Imperial Innovations has sold its portfolio company Permasense to Fortune 500 company Emerson Electric for an initial consideration of £30.6m in cash. Further amounts of up to £10m may be paid in addition, subject to the Permasense business achieving certain performance
Read more21 Sep 2016 12:23
Imperial Innovations invests £5.1m in new biotech start-up
(ShareCast News) - AIM-listed technology investor Imperial Innovations invested £5.1m in Artios Pharma, a new biotech start-up launched on Wednesday. Imperial Innovations contributed £5.1m to the £25m series A funding round, giving it a 14.9% interest in the new Cambridge- based company. Artios, wh
Read more19 Aug 2016 09:23
Cambridge University innovation investor raises 75 million pounds
LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital, which commercializes technology and healthcare research from Cambridge University, has raised 75 million pounds ($98 million) from investors, including for the first time Woodford Investment Management. CIC, founded in 2013, has alrea
Read more